40 results
424B5
SLNO
Soleno Therapeutics Inc
29 Sep 23
Prospectus supplement for primary offering
4:51pm
could result, including:
we may be forced to recall such product and suspend the marketing of such product;
regulatory authorities may withdraw … and the general public have raised concerns about potential drug safety issues. These events have resulted in the recall and withdrawal of drug products
424B5
SLNO
Soleno Therapeutics Inc
27 Sep 23
Prospectus supplement for primary offering
5:26pm
consequences could result, including:
we may be forced to recall such product and suspend the marketing of such product;
regulatory authorities may … professionals and the general public have raised concerns about potential drug safety issues. These events have resulted in the recall and withdrawal of drug
424B5
SLNO
Soleno Therapeutics Inc
30 Mar 22
Prospectus supplement for primary offering
5:21pm
to recall such product and suspend the marketing of such product;
regulatory authorities may withdraw their approvals of such product;
regulatory … in the recall and withdrawal of drug products, revisions to drug labeling that further limit use of the drug products and establishment of risk management
424B5
1n7vc7i0f1u1iq14l2
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-1.1
zjnprmc0
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
424B5
gce75p4j 4tine
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
xycdbd2n
23 Jun 20
Prospectus supplement for primary offering
4:06pm
424B5
yau43thb hffre7n82cj
25 Oct 19
Prospectus supplement for primary offering
12:00am
424B5
gk0xu799no ekyf
22 Oct 19
Prospectus supplement for primary offering
4:24pm
424B3
eltzbe3e an767ptfmk
12 Apr 19
Prospectus supplement
4:41pm